Viewing Study NCT06610474



Ignite Creation Date: 2024-10-26 @ 3:41 PM
Last Modification Date: 2025-12-16 @ 11:20 PM
Study NCT ID: NCT06610474
Status: None
Last Update Posted: 2025-10-06 00:00:00
First Post: 2024-09-20 00:00:00

Brief Title: Evaluation of an Online Prostate Cancer Screening Decision Aid
Sponsor: None
Organization: Centers for Disease Control and Prevention

Study Overview

Official Title: Evaluation of an Online Prostate Cancer Screening Decision Aid
Status: None
Status Verified Date: 2025-09
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Goal of the project: To conduct a randomized controlled trial (RCT) to determine if CDC's online, simulated, human decision aid module, Talk to Nathan About Prostate Cancer Screening (treatment arm), is effective in improving knowledge, overcoming health literacy barriers, and resolving decisional conflict compared to a standard decision aid (control arm 1) and standard education materials (control arm 2). Also, to identify barriers and best practices for incorporating Talk to Nathan About Prostate Cancer Screening into the flow of primary care practice.

Intended use of the resulting data: To measure evaluation outcomes, understand how to help men make decisions about the harms and benefits of prostate cancer screening that are in line with the patient's individual values and preferences, and make recommendations for improving the Talk to Nathan About Prostate Cancer Screening decision aid and incorporating it into primary care practice.

Methods to be used to collect: The RCT is a three-group parallel design with one treatment arm and two control arms. Data will be collected from all arms using a pre-exposure survey, a post-exposure survey, and a post-clinic visit survey. The treatment arm will also complete a usability survey and a subset of the treatment arm will be invited to participate in user experience interviews. Health care providers at the four participating clinics will complete a short survey prior to executing the three-arm study and interviews will be conducted at the close of the study with study coordinators from the four participating clinics.

The subpopulation to be studied: For the pre- and post-surveys, the usability survey, and the user experience interviews, the subpopulation is men aged 55-69 years. For the provider survey, the subpopulation is primary care providers who practice within the four clinics participating in the study. For the clinic coordinator interviews, the subpopulation is the study coordinators from the four participating clinics.

How data will be analyzed: For quantitative survey data: intention-to-treat analysis; repeated measures analysis of variance across assessment time points; ordinary least squares regression; complier-average causal effect (CACE) approach to calculate treatment effect; maximum likelihood and Bayesian inferential methods for CACE. For qualitative data from the surveys and interviews: We will identify and analyze themes, patterns, and inter-relationships relevant to the evaluation questions for this study.
Detailed Description: Goal of the project To conduct a randomized controlled trial RCT to determine if CDCs online simulated human decision aid module Talk to Nathan About Prostate Cancer Screening treatment arm is effective in improving knowledge overcoming health literacy barriers and resolving decisional conflict compared to a standard decision aid control arm 1 and standard education materials control arm 2 Also to identify barriers and best practices for incorporating Talk to Nathan About Prostate Cancer Screening into the flow of primary care practice

Intended use of the resulting data To measure evaluation outcomes understand how to help men make decisions about the harms and benefits of prostate cancer screening that are in line with the patients individual values and preferences and make recommendations for improving the Talk to Nathan About Prostate Cancer Screening decision aid and incorporating it into primary care practice

Methods to be used to collect The RCT is a three-group parallel design with one treatment arm and two control arms Data will be collected from all arms using a pre-exposure survey a post-exposure survey and a post-clinic visit survey The treatment arm will also complete a usability survey and a subset of the treatment arm will be invited to participate in user experience interviews Health care providers at the four participating clinics will complete a short survey prior to executing the three-arm study and interviews will be conducted at the close of the study with study coordinators from the four participating clinics

The subpopulation to be studied For the pre- and post-surveys the usability survey and the user experience interviews the subpopulation is men aged 55-69 years For the provider survey the subpopulation is primary care providers who practice within the four clinics participating in the study For the clinic coordinator interviews the subpopulation is the study coordinators from the four participating clinics

How data will be analyzed For quantitative survey data intention-to-treat analysis repeated measures analysis of variance across assessment time points ordinary least squares regression complier-average causal effect CACE approach to calculate treatment effect maximum likelihood and Bayesian inferential methods for CACE For qualitative data from the surveys and interviews We will identify and analyze themes patterns and inter-relationships relevant to the evaluation questions for this study

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None